PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PetVivo's free cash flow for the twelve months ending Mar 31, 2026 was -$6.12M. For fiscal 2026 it was -$6.12M. The highest annual figure on record is -$179.48K in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$6.12M | – |
| FY2025 | Mar 31, 2025 | -$5.39M | – |
| FY2024 | Mar 31, 2024 | -$7.73M | – |
| FY2023 | Mar 31, 2023 | -$7.22M | – |
| FY2022 | Mar 31, 2022 | -$4.33M | – |
| FY2021 | Mar 31, 2021 | -$907.85K | – |
| FY2020 | Mar 31, 2020 | -$530.88K | – |
| FY2019 | Mar 31, 2019 | -$763.56K | – |
| FY2018 | Mar 31, 2018 | -$594.43K | – |
| FY2017 | Mar 31, 2017 | -$179.48K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$978.15K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$812.38K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$1.46M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$1.25M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$984.85K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$1.60M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.55M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.55M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.48M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.49M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.21M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$1.42M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$1.96M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.11M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.73M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$1.71M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$1.26M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$12.58K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$341.09K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$277.61K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$276.57K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$114.74K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$143.29K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$160.81K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$191.69K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$267.79K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$339.81K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$53.87K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$59.70K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$8.37K | – |
See a number that looks wrong?